Countries using and planning to introduce IPV April 2015 status report This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine IPV ID: 139626
Download Presentation The PPT/PDF document "Countries using and planning to introduc..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Countries using and planning to introduce IPVSlide2
Countries using and planning to introduce IPVApril 2015 status report
This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV).
Information here is updated monthly based on information shared by WHO and UNICEF Regional Offices. Please contact
polio2@who.int
with any questions or updates on this data.
Definitions
Formal decision
to introduce:
The country has documentation of its decision
to introduce
IPV which has
been verified by the relevant WHO Regional
Office, or for
Gavi
eligible countries, a complete application for IPV has been submitted to the
Gavi
Secretariat.
Intent
to introduce:
The country has informally indicated that it plans to introduce IPV, e.g. planning an application
to
Gavi
, or by requesting technical
assistance to
develop an
IPV introduction
plan.
Tracking
these
decisions and informal
intents provide an indication of the global trend towards meeting
the targets of the
Polio Eradication and Endgame Strategic Plan
.Slide3
Countries using IPV vaccine to date and formal decision/intent to introduce
Data source: WHO/IVB Database, as of 02 April 2015Map production Immunization Vaccines and Biologicals (IVB),World Health Organization
Date of slide: 2 April 2015
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.
Introduced to date
(84 countries or 43%)
Formal commitment to introduce in 2015
(104 countries or 54%)
(4 countries or 2%)
(2 countries or 1%)
Not Available
Not applicable
Intend to introduce in 2016 (Thailand)
Formal commitment to introduce in 2016 (Saint Lucia)
Intend to introduce in 2015
(Cook Islands, Fiji, Mauritius, Turkmenistan)
Since January 2013, the following countries have introduced IPV:
Kazakhstan & Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July 2014); Nepal (September 2014); Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros (January 2015); Senegal (January 2015); Serbia (January 2015); Colombia (February 2015); Nigeria (February 2015); Bangladesh (March 2015) and Maldives (March 2015) Slide4
Non
Gavi countries with intent to introduce in 2015-16(Cook Islands, Fiji, Mauritius, Thailand, Turkmenistan)
Countries using IPV vaccine to date and introductions planned according to
Gavi
eligibility status
Data source: WHO/IVB Database, as of 02 April 2015
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Date of slide: 2 April 2015
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.
Introduced to date 2015
(84 countries or 43%)
All
Gavi
countries with formal commitment to introduce in 2015
(67 countries or 34.5%)
(38 countries or 20%)
(5 countries or 2.5%)
Not applicable
Since January 2013, the following countries have introduced IPV:
Kazakhstan & Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July 2014); Nepal (September 2014); Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros (January 2015); Senegal (January 2015); Serbia (January 2015); Colombia (February 2015); Nigeria (February 2015); Bangladesh (March 2015) and Maldives (March 2015)
Non
Gavi
countries with formal commitment to introduce in 2015-16Slide5
108 countries introducing IPV between April 2015 and December 2015
Yemen
and
Mauritius
are
introducing
in 2015 but no
month
of introduction
available. Saint
Lucia and Thailand are introducing in 2016. Tier 1 countries
are countries with
cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countries
Tier 2 countries are countries with cVDPV 1/3 since 2000 or large /medium size countries with DTP3 coverage <80% in the past 3 years
as per WUENIC
Source: WHO/UNICEF
database as at 02 April 2014Slide6
Tier 1 and 2 Countries
using IPV vaccine to date and formal decision to introduce
Formal commitment to introduce
in 2015
(32 countries or 91%)
Not Applicable or not Tier 1 or 2 countries
Data source: WHO/IVB Database, as of 02 April 2015 based on 35 tier 1 &2 countries
Map production: Immunization Vaccines and Biologicals (IVB),
World Health Organization
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.
Since January 2013, the following Tier 1 and 2 countries have introduced IPV:
Philippines (October 2014); China (December 2014) and Nigeria (February 2015)
Introduced to date
Tier
1 countries are countries
with
cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countries
Tier 2 countries are countries with
cVDPV 1/3 since 2000 or large /Medium size countries with DTP3 coverage <80% in the past 3 years as per WUENIC (3 countries or 9%)Slide7
Middle Income Countries
using IPV vaccine to date and formal/intent decision to introduce
Data source: WHO/IVB Database, as of 02 April 2015 based on 100 middle income countries (MIC) as per last WB classification
Map production: Immunization Vaccines and Biologicals (IVB),
World Health Organization
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2015. All rights reserved.
Introduced to date
(32 countries or 32%)
Formal commitment to introduce
in 2015
(63 countries or 63%)
Intend to introduce in 2015
(Fiji, Mauritius, Turkmenistan)
(3 countries or 3%)
Intend to introduce in 2016 (Thailand)
Formal commitment to introduce in 2016 (Saint Lucia)
(2 country or 2%)
Not Available
Not
applicable or not a MIC
Since January 2013, the following MIC have introduced IPV:
Kazakhstan (July 2013); Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July 2014); Tunisia (September 2014); Philippines (October 2014); China (December 2014); Senegal (January 2015); Serbia (January 2015); Colombia (February 2015) and
M
aldives (March 2015) Slide8
IPV Introduction
status and planned introduction by 2015
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.
WHO
2014.
All rights reserved
Introduced to date
(84 countries or 43%)
Introduction planned in Q2 2015
Introduction planned in
Q3 2015
(24 countries or 12%)
Introduction planned in 2016 (
Thailand, Saint
Lucia) or planned in 2015 but month of introduction not known (
M
auritius and Yemen)
Not Available
Not
applicable
Introduction planned in
Q4 2015
(42 countries or 22%)
(40 countries or 21%)
Data source: WHO/IVB Database, as of 02 April 2015
Map production: Immunization Vaccines and Biologicals (IVB),
World Health Organization
Since January 2013, the following countries have introduced IPV:
Kazakhstan (July 2013); Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July 2014); Nepal (September 2014); Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros (January 2015); Senegal (January 2015); Serbia (January 2015); Colombia (February 2015) and Nigeria (February 2015), Bangladesh (March 2015) and
Maldives (March 2015)